PLLWF (Polarean Imaging) Research & Development: $3.10 Mil (TTM As of Jun. 2025)


What is Polarean Imaging Research & Development?

Polarean Imaging PLLWF +560.00% Research & Development is $3.10 Mil as of Jun. 2025. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Polarean Imaging's Research & Development for the six months ended in Jun. 2025 was $1.49 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was $3.10 Mil.

Polarean Imaging  (OTCPK:PLLWF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Polarean Imaging Research & Development Related Terms

Polarean Imaging Research & Development Historical Data

* Premium members only.

The historical data trend for Polarean Imaging's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polarean Imaging Research & Development Chart

Polarean Imaging Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 5.63 4.19 3.44

Polarean Imaging Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.46 1.73 1.83 1.61 1.49

Polarean Imaging Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $3.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $3.10 Mil mean?
Polarean Imaging (PLLWF) has a Research & Development of $3.10 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Polarean Imaging and its competitors.
Is Polarean Imaging's Research & Development too high?
Polarean Imaging's current Research & Development is $3.10 Mil.
How does Polarean Imaging's Research & Development compare to FOFA and BTCY?
Polarean Imaging's Research & Development of $3.10 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Polarean Imaging and its competitors. Polarean Imaging's current Research & Development is $3.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (PLLWF) has a current Research & Development of $3.10 Mil. The stock's GF Value™ is $0.04, compared to a current price of $0.01 — trading 83.5% below its estimated fair value. The current Research & Development is $3.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Polarean Imaging (PLLWF), the current Research & Development is $3.10 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Polarean Imaging Business Description

Address 27-28 Eastcastle Street, London, GBR, W1W 8DH
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.